SciELO - Scientific Electronic Library Online

 
vol.52 número1Telarca precoce: avaliação clínica e laboratorial pelo método imunoquimioluminescenteTriiodotironina (T3) não induz a expressão de Rankl em células de rato ROS 17/2.8 índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Arquivos Brasileiros de Endocrinologia & Metabologia

versão impressa ISSN 0004-2730

Resumo

LEITE, Flavia M. et al. Comparative study of prednisolone versus hydrocortisone acetate for treatment of patients with the classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Arq Bras Endocrinol Metab [online]. 2008, vol.52, n.1, pp. 101-108. ISSN 0004-2730.  http://dx.doi.org/10.1590/S0004-27302008000100014.

Hydrocortisone acetate is usually employed in the treatment of classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. In Brazil, however, oral hydrocortisone acetate is only available from manipulation pharmacies. Prednisolone has stable oral pharmaceutical formulations commercially available, with the advantage of a single daily dose. The aim of this study was to compare the efficacy of oral prednisolone and oral hydrocortisone in the treatment of CAH due to 21-hydroxylase deficiency. Fifteen patients with mean (SD) chronological age of 7.2 (3.6) years, were evaluated in two consecutive 1-year periods. In the first year, hydrocortisone (17.5mg/m2/day, divided in three doses) was used in the treatment, followed by the use of prednisolone (3 mg/m²/day, once in the morning) in the second year. The comparison between the two treatments was assessed after a one-year treatment period by: variation of height standard deviation score (SDS) (D Height SDS), variation of height SDS according to bone age (D BA SDS), variation of body mass SDS (D BMI SDS) and serum levels of androstenedione. No significant difference was observed in relation to the D Height SDS, D BA SDS and D BMI SDS. No significant difference was observed in the serum levels of androstenedione. We conclude that the efficacy of prednisolone administered once a day orally is comparable to the oral use of hydrocortisone three times a day. Oral prednisolone may be an option for patients with CAH due to 21-hydroxylase deficiency.

Palavras-chave : Congenital adrenal hyperplasia; 21-hydroxylase; Prednisolone; Hydrocortisone.

        · resumo em Português     · texto em Português     · pdf em Português